David M Loeb

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Affordable Care Act

Coronavirus Disease

Top Venues

Pediatric blood & cancer

JCO precision oncology

Clinical sarcoma research

This page only lists publications with an associated author ORCID identifier.

Publications

Rachel Offenbacher, Lara Fabish, Jennifer Oliver-Krasinski, David M Loeb, Alissa Baker
Pembrolizumab as maintenance therapy for malignant rhabdoid tumor. Pediatric blood & cancer 69 (10) (2022)
Lauren Victoria Ghazal, Steve Cole, John M Salsman, Lynne I Wagner, Fenghai Duan, Ilana F Gareen, Lauren Lux, Susan K Parsons, Christabel K Cheung, David M Loeb, Pinki Prasad, Shira Dinner, Brad Zebrack
Social Genomics as a Framework for Understanding Health Disparities Among Adolescent and Young Adult Cancer Survivors: A Commentary. JCO precision oncology 6 (2022)
Rachel Offenbacher, Lara Fabish, Alissa Baker, David M Loeb
SARS-CoV-2 as a mimicker of pulmonary metastasis in osteosarcoma. Pediatric blood & cancer (2021)
Rachel Offenbacher, Miriam A Knoll, David M Loeb
Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID-19. Pediatric blood & cancer 68 (2) (2020)
Matteo M Trucco, Christian F Meyer, Katherine A Thornton, Preeti Shah, Allen R Chen, Breelyn A Wilky, Maria A Carrera-Haro, Lillian C Boyer, Margaret F Ferreira, Umber Shafique, Jonathan D Powell, David M Loeb
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas. Clinical sarcoma research 8 (2018)